CVR number 28136285
Industry 86.2200 Specialist medical practice activities

SPECIALLÆGESELSKABET KIM MØLLER-ANDERSEN ApS

 

Quicksearch
from your own companies
Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...
Bankruptcy Risk 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Bankruptcy risk for industry  0.7% 0.7% 0.7% 0.7% 0.7%  
Bankruptcy risk  0.9% 1.0% 1.3% 0.9% 1.7%  
Credit score (0-100)  89 87 79 88 72  
Credit rating  A A A A A  
Credit limit (kDKK)  174.9 142.3 30.0 160.8 2.2  
How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales  0 0 0 0 0  
Gross profit  2,145 1,842 2,284 2,134 1,988  
EBITDA  528 149 403 303 13.9  
EBIT  445 41.4 295 226 -74.7  
Pre-tax profit (PTP)  514.0 317.7 95.6 261.2 84.5  
Net earnings  379.3 265.3 72.6 203.4 59.4  
Pre-tax profit without non-rec. items  514 318 95.6 261 84.5  
 
See the entire income statement

Balance sheet (kDKK) 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Tangible assets total  301 562 599 521 547  
Shareholders equity total  1,484 1,638 1,598 1,687 1,628  
Interest-bearing liabilities  14.8 11.5 10.8 6.1 0.0  
Balance sheet total (assets)  2,234 2,301 2,122 2,219 2,151  
Net Debt  -1,577 -1,506 -1,208 -1,344 -1,272  
 
See the entire balance sheet

Volume 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  2,145 1,842 2,284 2,134 1,988  
Gross profit growth  31.3% -14.1% 24.0% -6.6% -6.8%  
Employees  0 0 2 2 2  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  2,234 2,301 2,122 2,219 2,151  
Balance sheet change%  32.9% 3.0% -7.7% 4.6% -3.1%  
Added value  527.7 148.6 402.5 332.8 13.9  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -50 154 -70 -154 -63  
Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  1.0 2.0 3.0 4.0 -1.0  

Profitability 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  20.7% 2.2% 12.9% 10.6% -3.8%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  26.3% 14.0% 14.0% 12.1% 3.9%  
ROI %  37.3% 19.9% 18.5% 15.4% 5.0%  
ROE %  28.1% 17.0% 4.5% 12.4% 3.6%  

Solidity 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Equity ratio %  66.4% 71.2% 75.3% 76.0% 75.7%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -298.8% -1,013.3% -300.0% -443.8% -9,144.1%  
Gearing %  1.0% 0.7% 0.7% 0.4% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  0.5% 5.6% 1,911.0% 15.1% 45.3%  

Liquidity 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Quick Ratio  2.6 2.7 3.1 3.5 3.4  
Current Ratio  2.6 2.7 3.1 3.5 3.4  
Cash and cash equivalent  1,591.7 1,517.4 1,218.4 1,350.1 1,272.0  

Capital use efficiency 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  678.1 66.0 192.4 348.3 145.8  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 201 166 7  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 201 151 7  
EBIT / employee  0 0 148 113 -37  
Net earnings / employee  0 0 36 102 30